You just read:

MGB Biopharma Closes $1 million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)

News provided by

MGB Biopharma

Apr 06, 2017, 04:00 ET